Current Epilepsy Center Clinical Trials
An Open-Label Study to Investigate the Safety and Pharmacokinetics of Single and Multiple Ascending Doses of Antisense Oligonucleotide STK-001 in Children and Adolescents with Dravet Syndrome
An Open-Label Extension Study for Patients with Dravet Syndrome who Previously Participated in Studies of STK-001
Natural History Study of Infants and Children with SCN1A-positive (SCN1A+) Dravet (ENVISION)
A Phase 3 Study of Adjunctive XEN496 in Pediatric Subjects with KCNQ2 Developmental and Epileptic Encephalopathy
An Open-label, Randomized Trial to Assess the Safety, Pharmacokinetics, and Exploratory Efficacy of Adjunctive Cannabidiol Oral Solution (GWP42003-P) Compared with Standard of Care Antiepileptic Therapy, in Patients Age 1 Month to Less Than 12 Months of Age with Tuberous Sclerosis Complex Who Experience Inadequately-controlled Seizures
Copper Histidinate Treatment for Menkes Disease
Ketogenic Diet with D,L-Beta-Hydroxybutyrate Medical Food Formulation for Pediatric Patients with Drug Resistant Epilepsy (KEEPER)
- IRB #: 2020-3267
- Study Contact: Enrique Rojas, erojas@luriechildrens.org & Marija Stosic, mstosic@luriechildrens.org
- PI: Dr. Joyce Wu
- Description: This is an interventional study to assess the safety and tolerability of the ketogenic diet in combination with a ketogenic medical food formulation (medium chain triglycerides and beta-hydroxybutyrate, MCT and BHB) for use in children with drug resistant seizures.